The report is designed to guide the decision-making of cord blood banks worldwide and to advise private, corporate, and institutional investors entering the cord blood banking market. It outlines the industry’s potential for the next several years and how investors can capitalize on emerging opportunities. It differs from "Complete 2012-13 U.S. Cord Blood Banking Industry Report" in that it is an overview of how to profit from global growth in the cord blood banking industry, rather than from the U.S. markets alone.
In reference to the “Expectant Parent Survey” contained within the report, “The report provides insights into the minds of over 200 expectant parents worldwide, revealing how they learn about, assess, and decide to purchase cord blood banking services. You can apply these insider insights to effectively position your cord blood banking services and have parents pursuing you for the opportunity to buy.”
As the global leader in supplying stem cell industry data - http://www.reportsnreports.com/tags/stem-cell-market-research.html , “BioInformant has already served most of the world’s leading cord blood banks, including the Virgin Health Bank, Cryo-Save, Cells for Life, CordLife, and many more. Others that will be served by the industry report include investors entering the cord blood banking market, as well as government representatives responsible for instituting public cord blood banking systems.”
On the necessity of the report to the success of cord blood banks, Lance Breastgoff pointed out, “Other companies have already claimed this report and are implementing services and strategies based on it. Can you afford to let them have that edge in an indust
Copyright©2012 Vocus, Inc.
All rights reserved